RUNX3 inhibits the proliferation and metastasis of gastric cancer through regulating miR-182/HOXA9.

CONCLUSIONS: RUNX3 could impede the ability of GC cells proliferation, migration and invasion by modulating miR-182/HOXA9 pathway.
PMID: 29054094 [PubMed - as supplied by publisher]

Source: Biomedicine and pharmacotherapy = Biomedecine and pharmacotherapie - October 17, 2017 Category: Drugs & Pharmacology Authors: Yu J, Tian X, Chang J, Liu P, Zhang R Tags: Biomed Pharmacother Source Type: research